Repositorio Dspace

Listar por tema "Neoplasm, Residual/diagnosis"

Listar por tema "Neoplasm, Residual/diagnosis"

Ordenar por:Orden:Resultados:

  • Prognostic Value of Serum Paraprotein Response Kinetics in Patients With Newly Diagnosed Multiple Myeloma 
    Tamariz-Amador, Luis-Esteban; Rodríguez-Otero, Paula; Jiménez-Ubieto, Ana; Rosiñol, Laura; Oriol, Albert; Ríos, Rafael; Sureda, Anna; Blanchard, María-Jesús; Teodoro-Hernández, Miguel; Cabanas-Perianes, Valentín; Jarque, Isidro; Bargay, Juan; Gironella, Mercedes; de-Arriba-de-la-Fuente, Felipe; Palomera, Luis; González-Montes, Yolanda; Marti, Josep-M; Krsnik, Isabel; Arguiñano, JM; Esther-González, María; Felipe-Casado, Luis; González-Rodríguez, Ana-Pilar; López-Anglada, Lucía; Puig, Noemi; Cedena, María-Teresa; Paiva, Bruno; Mateos, María-Victoria; San-Miguel, Jesús-F; Lahuerta, Juan-José; Blade, Joan; Troconiz, Inaki-F (CIG MEDIA GROUP, LP, 2022-09)
    INTRODUCTION: Response kinetics is a well-established prognostic marker in acute lymphoblastic leukemia. The situation is not clear in multiple myeloma (MM) despite having a biomarker for response monitoring (monoclonal ...
  • Recovery of uninvolved heavy/light chain pair immunoparesis in newly diagnosed transplant-eligible myeloma patients complements the prognostic value of minimal residual disease detection 
    Lakhwani, Sunil; Rosiñol, Laura; Puig, Noemi; Pico-Picos, Miguel-Ángel; Medina-González, Laura; Martínez-López, Joaquín; Paiva, Bruno; Cedena, María-Teresa; Oriol, Albert; Ríos-Tamayo, Rafael; Blanchard, María-Jesús; Jarque, Isidro; Bargay, Joan; Moraleda-Jiménez, José-María; Carrillo-Cruz, Estrella; Sureda, Anna; Krsnik, Isabel; González, Esther; Casado-Montero, Luis-Felipe; Martí, Josep-M; Encinas, Cristina; de-Arriba-de-la-Fuente, Felipe; Palomera, Luis; Sampol, Antonia; González-Montes, Yolanda; Motllo, Cristina; de-La-Cruz, Javier; Alonso, Rafael; Mateos, María-Victoria; Blade, Joan; Lahuerta, Juan-José; San-Miguel, Jesús-F; Hernández-García, Miguel-Teodoro (FERRATA STORTI FOUNDATION, 2024-06)
    Immunoparesis (IP) in multiple myeloma (MM) patients can be measured by classic assessment of immunoglobulin (Ig) levels or by analysis of the uninvolved heavy/light chain pair of the same immunoglobulin (uHLC) by the ...
  • Single-point and kinetics of peripheral residual disease by mass spectrometry to predict outcome inpatients with high-risk smoldering multiple myeloma included in the GEM-CESAR trial 
    Puig, Noemi; Agulló, Cristina; Contreras, Teresa; Pérez, José-Juan; Aires, Irene; Calasanz, María-José; García-Sanz, Ramón; Castro, Sergio; Martínez-López, Joaquín; Rodríguez-Otero, Paula; González-Calle, Verónica; González, Marta-S; Oriol, Albert; Gutiérrez, Norma-C; Ríos-Tamayo, Rafael; Rosiñol, Laura; Álvarez, Miguel-Ángel; Bargay, Joan; González-Rodríguez, Ana-Pilar; Alegre, Adrián; Escalante, Fernando; Iñigo, María-Belén; de-la-Rubia, Javier; Teruel, Ana-Isabel; de-Arriba-de-la-Fuente, Felipe; Palomera, Luis; Hernández-García, Miguel-Teodoro; López-Jiménez, Javier; Reinoso, Marta; García-Mateo, Aranzazu; Ocio, Enrique-M; Blade, Joan; Lahuerta, Juan-José; Cedena, María-Teresa; Paiva, Bruno; San-Miguel, Jesús-F; Mateos, María-Victoria (FERRATA STORTI FOUNDATION, 2024-12)
    The value of quantitative immunoprecipitation mass spectrometry (QIP-MS) to identify the M-protein is being investigated in patients with monoclonal gammopathies but no data are yet available in high-risk smoldering myeloma ...